These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Difficulties in diagnosing systemic lupus erythematosus in a patient with a history of tuberculosis]. Dettlaff Z Pol Tyg Lek; 1972 May; 27(21):794-5. PubMed ID: 4537320 [No Abstract] [Full Text] [Related]
25. Specificity of antinuclear factor testing: what does specific mean? Stark D; Stein HB; Boyko W Can Med Assoc J; 1980 Sep; 123(6):473-4, 476. PubMed ID: 7002273 [No Abstract] [Full Text] [Related]
27. [Systemic lupus erythematosus and HIV infection. A case report and review of the literature]. Calza L; Manfredi R; Colangeli V; Chiodo F Recenti Prog Med; 2002 Jan; 93(1):28-31. PubMed ID: 11850997 [TBL] [Abstract][Full Text] [Related]
29. What is lupus? What is not lupus? Panush RS; Greer JM; Morshedian KK Rheum Dis Clin North Am; 1993 Feb; 19(1):223-34. PubMed ID: 8356256 [TBL] [Abstract][Full Text] [Related]
30. Antinuclear antibodies in dermatology. Heffernan MP; Do JH; Mehta J Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133 [TBL] [Abstract][Full Text] [Related]
31. A case report of familial systemic lupus erythematosus. Mukherjee N; Dutta G; Deb S J Indian Med Assoc; 1996 May; 94(5):179-81. PubMed ID: 8855572 [No Abstract] [Full Text] [Related]
32. Greenwald's law of lupus: the Sontheimer amendment. Sontheimer RD J Rheumatol; 1993 Jul; 20(7):1258-9. PubMed ID: 8240543 [No Abstract] [Full Text] [Related]
33. Clinical utility of common serum rheumatologic tests. Lane SK; Gravel JW Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083 [TBL] [Abstract][Full Text] [Related]
34. [Significance of antinuclear antibodies for the diagnosis and activity of systemic lupus erythematosus]. Xie H; Liu Z; Zhu W Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):177-8. PubMed ID: 9868068 [No Abstract] [Full Text] [Related]
35. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic applications of antinuclear antibodies; specifics and non-specifics. Fox AL Minn Med; 1973 Jul; 56(7):589-92. PubMed ID: 4541435 [No Abstract] [Full Text] [Related]
38. Detecting clinical activity in systemic lupus erythematosus with an archaeal poly(ADP-ribose) polymerase-like thermozyme: a pivotal study. Faraone-Mennella MR; Scarpa R; Petrella A; Manguso F; Peluso R; Farina B Biomarkers; 2009 Sep; 14(6):381-7. PubMed ID: 19530912 [TBL] [Abstract][Full Text] [Related]
39. Anti-DNA antibodies by the Farr and the Crithidia luciliae assays and the clinical status of systemic lupus erythematosus. Lavalle C; Núñez A; Muñoz E Rev Invest Clin; 1981; 33(4):349-54. PubMed ID: 6977173 [No Abstract] [Full Text] [Related]
40. Laboratory tests in clinical immunology: a critique. Dawkins RL; Peter JB Am J Med; 1980 Jan; 68(1):3-5. PubMed ID: 6965337 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]